Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2022

      Share Article
      share to

      New Brunswick, NJ (October 19, 2022) – Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2022 of $1.13 per share on the company’s common stock. The dividend is payable on December 6, 2022 to shareholders of record at the close of business on November 22, 2022. The ex-dividend date is November 21, 2022.

      About Johnson & Johnson
      At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

      Press Contacts:
      Jake Sargent
      jsargen3@ITS.JNJ.com

      Investor Contacts:
      Jessica Moore
      jmoore29@its.jnj.com

      Sarah Wood
      swood15@its.jnj.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.